Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 8Completed 4Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 27toripalimab 14Radiotherapy 12Gemcitabine 12Capecitabine 11Radiotherapy, Intensity-Modulated 10pembrolizumab 9Surgical Procedures, Operative 9Docetaxel 9tislelizumab 8Carboplatin 7Drug Therapy 6Blood Specimen Collection 6anlotinib 5Taxes 5Paclitaxel 5Nivolumab 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cetuximab 5Thyroxine 4Cyclophosphamide 4130-nm albumin-bound paclitaxel 4trametinib 3sintilimab 3camrelizumab 3Specimen Handling 3Radiation 3Observation 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × nedaplatin × Head & Neck × Clear all
NCT03503136 2018-05-11

NX-NPC

Sun Yat-sen University

Phase 3 Not yet recruiting
632 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡